• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Italy·Consumer Cyclical·VLS.MI
Share

Valsoia S.p.A. Stocks

€ 10.35Last Updated 21.07.2026

Issuer Rating

4/7
Performance

Favourable

Risk

Considerable

Recommendation

Hold

Market Cap

€ 125.92M

€ 10.35
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Solid dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Valsoia S.p.A. is an Italian firm engaged in the manufacturing, distribution, and sale of a broad spectrum of consumer food products, with a primary focus on health-oriented items. Its diverse product range includes plant-based alternatives (notably soy-based), beverages, ice creams, yogurts, desserts, biscuits, ready-to-eat meals, cheeses, condiments, fruit preserves and products, and tomato purees and sauces, alongside various dietary and nutritional supplements. The company markets these goods under a host of brands, including Valsoia Bontà E Salute, Santa Rosa, Valsoia Integratori, Pomodorissimo, Weetabix, Oreo, Vitasoya, Diete.Tic, Piadina Loriana, and Naturattiva. Founded in 1990, Valsoia S.p.A. maintains its headquarters in Bologna, Italy, and functions as a subsidiary of Finsalute S.r.l.

Company Valuation

Slightly undervalued
5/7

From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks. Specifically, the stock is fairly valued on P/E, neutral o

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of VLS.MI is 13.5 and suggests 32.4% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

22.07.2026 19:53

50% Jump: Revolut Begins Secondary Share Offering at a Valuation of $115 Billion

22.07.2026 18:52

Nvidia has found a new way to boost sales. Why might this be a "red flag"?

22.07.2026 18:35

Simply Good Food: Why Could the Protein Snack Maker's Stock Rise by 35%?

22.07.2026 18:07

Wells Fargo sees gold's upside potential as three times greater than its downside potential

22.07.2026 17:40

This is the third time Deutsche Bank has been raided since the start of the year

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026